ERBB4 and central nervous system cancer: Genes from the RTK/PI3K pathway, including PTEN, PIK3R1 in glioma, and ALK, PIK3C2G, ERBB4 in melanoma, showed lower mutation rates in AYAs, reiterating our earlier observation on recurrent genes.